In some parts of the world, peritoneal dialysis is widely used for renal replacement therapy (RRT) in acute kidney injury (AKI), despite concerns about its inadequacy. It has been replaced in recent years by hemodialysis and, most recently, by continuous venovenous therapies. We performed a prospective study to determine the effect of continuous peritoneal dialysis (CPD), as compared with daily hemodialysis (dHD), on survival among patients with AKI.
Methods
A total of 120 patients with acute tubular necrosis (ATN) were assigned to receive CPD or dHD in a tertiary-care university hospital. The primary endpoint was hospital survival rate; renal function recovery and metabolic, acid–base, and fluid controls were secondary endpoints.
Results
Of the 120 patients, 60 were treated with CPD (G1) and 60 with dHD (G2). The two groups were similar at the start of RRT with respect to age (64.2 ± 19.8 years vs 62.5 ± 21.2 years), sex (men: 72% vs 66%), sepsis (42% vs 47%), shock (61% vs 63%), severity of AKI [Acute Tubular Necrosis Individual Severity Score (ATNISS): 0.68 ± 0.2 vs 0.66 ± 0.22; Acute Physiology and Chronic Health Evaluation (APACHE) II: 26.9 ± 8.9 vs 24.1 ± 8.2], pre-dialysis blood urea nitrogen [BUN (116.4 ± 33.6 mg/dL vs 112.6 ± 36.8 mg/dL)], and creatinine (5.85 ± 1.9 mg/dL vs 5.95 ± 1.4 mg/dL). In G1, weekly delivered Kt/V was 3.59 ± 0.61, and in G2, it was 4.76 ± 0.65 (p < 0.01). The two groups were similar in metabolic and acid–base control (after 4 sessions, BUN < 55 mg/dL: 46 ± 18.7 mg/dL vs 52 ± 18.2 mg/dL; pH: 7.41 vs 7.38; bicarbonate: 22.8 ± 8.9 mEq/L vs 22.2 ± 7.1 mEq/L). Duration of therapy was longer in G2 (5.5 days vs 7.5 days; p = 0.02). Despite the delivery of different dialysis methods and doses, the survival rate did not differ between the groups (58% in G1 vs 52% in G2), and recovery of renal function was similar (28% vs 26%).
Conclusion
High doses of CPD provided appropriate metabolic and pH control, with a rate of survival and recovery of renal function similar to that seen with dHD. Therefore, CPD can be considered an alternative to other forms of RRT in AKI.
WoodrowG., TurneyJ.H.Cause of death in acute renal failure.Nephrol Dial Transplant1992; 7: 230–4.
2.
ClermontG., AckerC.G., AngusD.C., SirioC.A., PinskyM.R., JohnsonJ.P.Renal failure in the ICU: comparison of the impact of acute renal failure and end-stage renal disease on ICU outcomes.Kidney Int2002; 62: 986–96.
3.
LiañoF., JuncoE., PascualJ., MaderoR., VerdeE.The spectrum of acute renal failure in the intensive care unit compared with that seen in other settings. The Madrid Acute Renal Failure Study Group.Kidney Int Suppl1998; (66): S16–24.
4.
de MendonçaA., VincentJ.L., SuterP.M., MorenoR., DeardenN.M., AntonelliM.Acute renal failure in the ICU: risk factors and outcome evaluated by the SOFA score.Intensive Care Med2000; 26: 915–21.
5.
PhuN.H., HienT.T., MaiN.T., ChauT.T., ChuongL.V., LocP.P.Hemofiltration and peritoneal dialysis in infection-associated acute renal failure in Vietnam.N Engl J Med2002; 347: 895–902.
6.
ChitaliaV.C., AlmeidaA.F., RaiH., BapatM., ChitaliaK.V., AcharyaV.N.Is peritoneal dialysis adequate for hypercatabolic acute renal failure in developing countries?Kidney Int2002; 61: 747–57.
7.
MehtaR.L., McDonaldB., GabbaiF.B., PahlM., PascualM.T., FarkasA.on behalf of the Collaborative Group for Treatment of ARF in the ICU. A randomized clinical trial of continuous versus intermittent dialysis for acute renal failure.Kidney Int2001; 60: 1154–63.
8.
UehlingerD.E., JakobS.M., FerrariP., EichelbergerM., Huynh–DoU., MartiH.P.Comparison of continuous and intermittent renal replacement therapy for acute renal failure.Nephrol Dial Transplant2005; 20: 1630–7.
9.
AugustineJ.J., SandyD., SeifertT.H., PaganiniE.P.A randomized controlled trial comparing intermittent with continuous dialysis in patients with ARF.Am J Kidney Dis2004; 44: 1000–7.
10.
VinsonneauC., CamusC., CombesA., Costa de BeauregardM.A., KloucheK., BoulainT.on behalf of the Hemodiafe Study Group. Continuous venovenous haemodiafiltration versus intermittent haemodialysis for acute renal failure in patients with multiple-organ dysfunction syndrome: a multicentre randomised trial.Lancet2006; 368: 379–85.
11.
ChoK.C., HimmelfarbJ., PaganiniE., IkizlerT.A., SorokoS.H., MehtaR.L.Survival by dialysis modality in critically ill patients with acute kidney injury.J Am Soc Nephrol2006; 17: 3132–8.
12.
HimmelfarbJ.Continuous dialysis is not superior to intermittent dialysis in acute kidney injury of the critically ill patient.Nat Clin Pract Nephrol2007; 3: 120–1.
13.
SchifflH., LangS.M., FischerR.Daily hemodialysis and the outcome of acute renal failure.N Engl J Med2002; 346: 305–10.
14.
ChughK.S., JhaV., SetprijaV.Acute renal failure in tropical countries. In: DavisonA.M., CameronJ.S., GrunfeldJ.P., eds. Oxford Textbook of Clinical Nephrology.New York: Oxford University Press; 1998: 1714–34.
MehtaR.L., LetteriJ.M.Current status of renal replacement therapy for acute renal failure. A survey of U.S. nephrologists. The National Kidney Foundation Council on Dialysis.Am J Nephrol1999; 19: 377–82.
KorbetM.S., KronfoO.N.Acute peritoneal dialysis prescription. In: DaugirdasT.J., BlakeP.G., IngT.S., eds. Handbook of Dialysis.3rd ed.Philadelphia: Lippincott Williams and Wilkins; 2001: 333–42.
27.
DrumlW.Nutrition support in acute renal failure. In: MitchW.E., KlahrS., eds. Handbook of Nutrition and the Kidney.3rd ed.Philadelphia: Lippincott–Raven Publishers; 1996:231–6.
28.
DaugirdasJ.T.Second generation logarithmic estimates of single-pool variable volume Kt/V: an analysis of error.J Am Soc Nephrol1993; 4: 1205–13.
29.
BargmanJ.M., BickJ., CartierP., DasguptaM.K., FineA., LavoieS.D.Guidelines for adequacy and nutrition in peritoneal dialysis. Canadian Society of Nephrology.J Am Soc Nephrol1999; 10(Suppl 13): S311–21.
30.
HimmelfarbJ., EvansonJ., HakimR.M., FreedmanS., ShyrY., IkizlerT.A.Urea volume of distribution exceeds total body water in patients with acute renal failure.Kidney Int2002; 61: 317–23.
31.
Du BoisD., Du BoisE.The measurement of the surface area of man.Arch Intern Med1915; 16: 868–81.
32.
ChumleaW.C., GuoS., RocheA.F., SteinbaughM.L.Prediction of body weight for the nonambulatory elderly from anthropometry.J Am Diet Assoc1988; 88: 564–8.
33.
RoncoC.Can peritoneal dialysis be considered an option for the treatment of acute kidney injury?Perit Dial Int2007; 27: 251–3.
34.
KellumJ.A., RoncoC., MehtaR., BellomoR.Consensus development in acute renal failure: The Acute Dialysis Quality Initiative.Curr Opin Crit Care2005; 11: 527–32.
35.
RoncoC., RicciZ., BellomoR., BaldwinI., KellumJ.Management of fluid balance in CRRT: a technical approach.Int J Artif Organs2005; 28: 765–76.
36.
UchinoS., KellumJ.A., BellomoR., DoigG.S., MorimatsuH., MorgeraS.on behalf of the Beginning and Ending Supportive Therapy for the Kidney (BEST Kidney) Investigators. Acute renal failure in critically ill patients: a multinational, multicenter study.JAMA2005; 294: 813–18.
37.
RoncoC.Continuous dialysis is superior to intermittent dialysis in acute kidney injury of the critically ill patient.Nat Clin Pract Nephrol2007; 2: 118–19.
38.
RoncoC.Factors affecting hemodialysis and peritoneal dialysis efficiency.Contrib Nephrol2006; 150: 1–12.
39.
RoncoC., AmerlingR.Continuous flow peritoneal dialysis: current state-of-the-art and obstacles to further development.Contrib Nephrol2006; 150: 310–20.
40.
GotchF.A.Kinetic modeling of continuous flow peritoneal dialysis.Semin Dial2001; 14: 378–83.
EvansonJ.A., HimmelfarbJ., WingardR., KnightsS., ShyrY., SchulmanG.Prescribed versus delivered dialysis in acute renal failure patients.Am J Kidney Dis1998; 32: 731–8.
43.
EvansonJ.A., IkizlerT.A., WingardR., KnightsS., ShyrY., SchulmanG.Measurement of the delivery of dialysis in acute renal failure.Kidney Int1999; 55: 1501–8.
44.
PaganiniE.P.Dialysis is not dialysis is not dialysis! Acute dialysis is different and needs help!Am J Kidney Dis1998; 32: 832–3.
45.
EknoyanG., LevinN.W., EschbachJ.W., GolperT.A., OwenW.F.Jr., SchwabS.on behalf of Baylor College of Medicine; Renal Research Institute; Beth Israel Hospital Center; Minor and James Medical Center; Vanderbilt University; Duke University Medical Center; Covance Health Economics and Outcomes Services; and Johns Hopkins University. Continuous quality improvement: DOQI becomes K/DOQI and is updated. National Kidney Foundation's Dialysis Outcomes Quality Initiative.Am J Kidney Dis2001; 37: 179–94.
46.
DaugirdasJ.T.Peritoneal dialysis in acute renal failure–why the bad outcome?N Engl J Med2002; 347: 933–5.
47.
BazariH.Hemofiltration and peritoneal dialysis in infection-associated acute renal failure.N Engl J Med2003; 348: 858–60.
48.
Gómez–FernándezP., Sánchez AgudoL., CalatravaJ.M., EscuinF., SelgasR., MartínezM.E.Respiratory muscle weakness in uremic patients under continuous ambulatory peritoneal dialysis.Nephron1984; 36: 219–23.
StrauchM., WalzerP., HenningG.E.Factors influencing protein loss during peritoneal dialysis.Trans Am Soc Artif Intern Organs1967; 13: 172–7.
51.
YeunJ.Y., KaysenG.A.Acute phase proteins and peritoneal dialysate albumin loss are the main determinants of serum albumin in peritoneal dialysis patients.Am J Kidney Dis1997; 30: 923–7.
